Published Works | Pharmaceutical Law & Industry Report | 30 April 2004

Medicare Act Increases Risk of Declaratory Judgment Actions Against Innovators

Although not widely publicized, several provisions of the Medicare Prescription Drug, Modernization, and Improvement Act (the Medicare Act) may prove important to innovator pharmaceutical companies.

Download PDF Back To Listing